Early Illness Features Associated With Mortality in the Juvenile Idiopathic Inflammatory Myopathies

Abstract

Overall mortality was higher in juvenile IIM patients, and several early illness features were identified as risk factors. Clinical subgroup, antisynthetase autoantibodies, older age at diagnosis, and ILD are also recognized as mortality risk factors in adult myositis.

References

Page 1

	Year	Citations
Random survival forests The Annals of Applied Statistics EpidemiologyEngineeringMachine LearningData ScienceData Mining	2008	2.3K
A New Approach to the Classification of Idiopathic Inflammatory Myopathy Lori A. Love, Richard L. Leff, D. D. Fraser, Medicine ImmunologyPathologyAxial SpondyloarthritisIdiopathic Inflammatory MyopathyInflammation	1991	969
Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features Katalin Dankó, Andrea Ponyi, Tamás Constantin, Medicine	2004	330
Anti–signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy Amy Kao, David Lacomis, Mary Lucas, Arthritis & Rheumatism	2004	283
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies Lisa G. Rider, Mona Shah, Gulnara Mamyrova, Medicine ImmunologyPathologyMyositis Autoantibody PhenotypesChronic Illness CourseSkeletal Muscle Weakness	2013	283
The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr Liza McCann, Audrey Juggins, S. Maillard, Lara D. Veeken	2006	279
Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody I. Marie, P.Y. Hatron, S. Dominique, Seminars in Arthritis and Rheumatism Rheumatoid DisorderRheumatologyAutoimmune DiseaseLupus NephritisImmunology	2011	222
Long-term outcome in polymyositis and dermatomyositis I. M. Bronner, M. F. G. van der Meulen, Marjolein Visser, Annals of the Rheumatic Diseases	2006	213
Random Survival Forests for R Hemant Ishwaran, Udaya B. Kogalur	2007	204
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities F. M. Cox, Maarten J. Titulaer, Jacob K. Sont, Brain End StageQuantitative Muscle TestingProgressive MyopathyQuantitative Muscle TestsApplied Physiology	2011	197

Page 1